Median Technologies

📍 Valbonne, France🗓 Founded 2002👥 231 employees💰 Last funded Dec 2019
Median Technologies provides innovative imaging solutions and services to advance healthcare for everyone. We harness the power of medical images by using the most advanced Artificial Intelligence technologies, to increase the accuracy of diagnosis and treatment of many cancers and other metabolic diseases at their earliest stages and provide insights into novel therapies for patients. Our iCRO solutions for medical image analysis and management in oncology trials and eyonis™, our AI/ML tech-based suite of software as medical devices (SaMD) help biopharmaceutical companies and clinicians to bring new treatments and diagnose patients earlier and more accurately. This is how we are helping to create a healthier world. Founded in 2002, based in Sophia-Antipolis, France, with a subsidiary in the US and another one in Shanghai, Median has received the label “Innovative company” by the BPI and is listed on Euronext Growth market (Paris). FR0011049824– ticker: ALMDT. Median is eligible for the French SME equity savings plan scheme (PEA-PME).
3
Total investors
1
Early stage
0
Mid stage
0
Late stage
2002
Founded
Investor geography2 countries
France
2
United States
1
Investor activity2004–2019 · investors recorded per year
200412016120191
Recent (last 2y)Earlier
Frequently asked questions
Who invested in Median Technologies?
Median Technologies has 3 investors on record on gritt.io, including 1 early-stage backers.
When did Median Technologies last raise funding?
The most recent investment in Median Technologies recorded on gritt.io was in December 2019.
When was Median Technologies founded?
Median Technologies was founded in 2002.
What industry is Median Technologies in?
Median Technologies operates in Software Development. Find similar Software Development investors on gritt.io.
Where is Median Technologies based?
Median Technologies is headquartered in Valbonne, France.